对《体外诊断IVD应用中甲基化生物标志物的开发现状》的更正
Correction to: Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.
作者信息
Taryma-Leśniak Olga, Sokolowska Katarzyna Ewa, Wojdacz Tomasz Kazimierz
机构信息
Independent Clinical Epigenetics Laboratory, Pomeranian Medical University, Unii Lubelskiej 1, 71-252, Szczecin, Poland.
出版信息
Clin Epigenetics. 2020 Jul 14;12(1):107. doi: 10.1186/s13148-020-00902-9.
Abstract
An amendment to this paper has been published and can be accessed via the original article.
摘要
本文的一篇修正已发表，可通过原始文章获取。
相似文献
1
Correction to: Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.对《体外诊断IVD应用中甲基化生物标志物的开发现状》的更正
Clin Epigenetics. 2020 Jul 14;12(1):107. doi: 10.1186/s13148-020-00902-9.
2
Correction to: DNA methylation changes during preimplantation development reveal interspecies differences and reprogramming events at imprinted genes.对《植入前发育过程中的DNA甲基化变化揭示了印记基因的种间差异和重编程事件》的修正
Clin Epigenetics. 2020 Jun 29;12(1):96. doi: 10.1186/s13148-020-00887-5.
3
Correction to: Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma.对《眶面部神经纤维瘤中HOX转录因子家族的差异基因甲基化与表达》的更正
Acta Neuropathol Commun. 2020 May 14;8(1):69. doi: 10.1186/s40478-020-00944-3.
4
Correction to: N‑Adenosine methylation on mRNA is recognized by YTH2 domain protein of human malaria parasite Plasmodium falciparum.对《人类疟原虫恶性疟原虫mRNA上的N-腺苷甲基化被YTH2结构域蛋白识别》一文的更正
Epigenetics Chromatin. 2020 Sep 22;13(1):36. doi: 10.1186/s13072-020-00357-5.
5
Correction to: Relevance of biomarkers across different neurodegenerative diseases.对《不同神经退行性疾病中生物标志物的相关性》的更正
Alzheimers Res Ther. 2020 Jun 9;12(1):71. doi: 10.1186/s13195-020-00637-y.
6
Publisher Correction: RdDM-independent de novo and heterochromatin DNA methylation by plant CMT and DNMT3 orthologs.出版商更正：植物CMT和DNMT3直系同源物介导的不依赖RdDM的从头和异染色质DNA甲基化。
Nat Commun. 2019 Jun 6;10(1):2552. doi: 10.1038/s41467-019-10558-6.
7
Correction to: Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy.对《DNA甲基化和基因表达的全基因组分析确定人类糖尿病性神经病变的候选基因》的更正
Clin Epigenetics. 2020 Aug 27;12(1):130. doi: 10.1186/s13148-020-00922-5.
8
Correction to: Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis.对《基于Logit模型分析确定的与乳腺癌复发相关的预后生物标志物》的更正
World J Surg Oncol. 2020 Dec 5;18(1):320. doi: 10.1186/s12957-020-02079-0.
9
Correction to: Epidermal stem cells in wound healing and their clinical applications.对《伤口愈合中的表皮干细胞及其临床应用》的更正
Stem Cell Res Ther. 2020 Oct 22;11(1):447. doi: 10.1186/s13287-020-01960-9.
10
Correction to: Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in western Mexico.对《墨西哥西部老年HIV阳性和HIV阴性人群的细菌群落、短链脂肪酸和生物标志物的变化》的更正
BMC Infect Dis. 2020 Oct 16;20(1):764. doi: 10.1186/s12879-020-05508-3.
引用本文的文献
1
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.循环生物标志物在肝细胞癌的诊断和治疗中的应用。
Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):670-681. doi: 10.1038/s41575-022-00620-y. Epub 2022 Jun 8.
2
and Methylation in Stool DNA for Early Detection of Colorectal Cancer.粪便DNA甲基化用于结直肠癌的早期检测
Front Oncol. 2021 Jan 29;10:621295. doi: 10.3389/fonc.2020.621295. eCollection 2020.
本文引用的文献
1
Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.用于体外诊断（IVD）应用的甲基化生物标志物的发展现状。
Clin Epigenetics. 2020 Jul 6;12(1):100. doi: 10.1186/s13148-020-00886-6.
Zotero 插件